Last info update: December 2022
Ramesh dass email & phone, vice president, head of market access, pricing and reimbursement - intl at Intercept pharmaceuticals

Ramesh Dass — Contact Information

Vice President, Head Of Market Access, Pricing And Reimbursement - Intl

Ramesh Dass's Email, Phone & Whatsapp Number and other Contact Information

  • Emails Email r***net
    Open contact Available for registered users
  • Location Location United Kingdom
  • Skills Skills Market Access · Healthcare · Pharmaceutical Industry · Oncology · Biotechnology · Health Economics · Medical Devices · Strategy · Medicine · Clinical Research · Pricing · Infectious Diseases · Project Management · Product Launch · Commercialization · Pharmaceutics · Pricing And Reimbursement · Health Economics And Outcomes · Informatics · Lifesciences · Consulting · Hospitals · Diabetes · Clinical Development · Medical Affairs · Life Sciences · Management · Clinical · Managed Care · Clinical Trials · Leadership · Strategic Planning · Management Consulting · Regulatory Aff

Ramesh Dassis a Vice President, Head Of Market Access, Pricing And Reimbursement - Intl. Works at Intercept Pharmaceuticals(United States). Located in United Kingdom. Open Ramesh Dass's email & phone: R***net. Skilled in Market Access · Healthcare · Pharmaceutical Industry · Oncology · Biotechnology · Health Economics · Medical Devices · Strategy · Medicine · Clinical Research · Pricing · Infectious Diseases · Project Management · Product Launch · Commercialization · Pharmaceutics · Pricing And Reimbursement · Health Economics And Outcomes · Informatics · Lifesciences · Consulting · Hospitals · Diabetes · Clinical Development · Medical Affairs · Life Sciences · Management · Clinical · Managed Care · Clinical Trials · Leadership · Strategic Planning · Management Consulting · Regulatory Aff.

Experience of Ramesh Dass

Ramesh dass's Company Details

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, a FXR modulating agent that tre Read more ats patients with chronic autoimmune liver diseases. The company's drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases. Intercept Pharmaceuticals, Inc. was founded in 2002 and is based in New York, New York.

  • Company Emails [email protected]
  • Company Phone 646-747-1000
  • Company Website interceptpharma.com
  • Company Location new york, new york, united states
  • Industry pharmaceuticals
  • Company Size 501-1000
  • Found Year 2022
Click to load map
Colleagues
Similar employees

Frequently Asked Questions

Directories